{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:52:02Z","timestamp":1781599922430,"version":"3.54.5"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Liver fibrosis due to alcohol consumption or chronic hepatitis B virus (HBV)-related liver disease is a major challenge for global health. Despite the different mechanisms of primary liver injury and disease-specific cell responses, the progression of fibrotic liver disease follows a shared pattern. Our research aimed to identify key factors associated with shared patterns of alcohol- or HBV-related liver fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Liver samples from three alcohol-related fibrosis patients, six HBV-related fibrosis patients, and five hepatic hemangioma patients were collected and grouped. Transcriptome and proteome sequencing were used to identify differentially expressed genes (DEGs) and differentially expressed proteins (DEPs) in alcohol- or HBV-related liver fibrosis hepatic stellate cells. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted to understand the functions of the DEGs or DEPs. Immunohistochemistry analysis, dual-luciferase reporter assays, Western blotting, real-time quantitative polymerase chain reaction, and chromatin immunoprecipitation were used to investigate annexin A2 (ANXA2) function and regulatory mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Transcriptomic analysis revealed 744 overlapping upregulated DEGs in patients with alcohol- or HBV-related liver fibrosis. GO and KEGG analyses revealed that 744 DEGs were involved in vasculature development and the extracellular matrix organization pathway. Proteomics revealed 99 overlapping upregulated DEPs in patients with alcohol- or HBV-related liver fibrosis. GO and KEGG analyses revealed that 99 DEPs were involved in phagosome and neutrophil degranulation. Integration of the transcriptome and proteome revealed that ANXA2 and perilipin 1 (PLIN1) might be key factors for the progression of liver fibrosis. Biochemical analysis revealed that ANXA2 positively regulates the process of liver fibrosis, whereas PLIN1 negatively regulates the process of liver fibrosis. Furthermore, the mechanisms by which ANXA2 is regulated by the NF-\u03baB pathway during alcohol consumption and by the Janus kinase\u2013signal transducer\/activator of transcription 3 pathway during HBV infection are well proved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our findings demonstrate that ANXA2 and PLIN1 are key factors involved in the progression of both alcohol- and HBV-related liver fibrosis, and further clarify the distinct regulatory mechanisms of ANXA2 mediated by the NF-\u03baB pathway in alcohol-induced fibrosis and in HBV-related fibrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000004155","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:00:54Z","timestamp":1781596854000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Multiomics contributes to the discovery of common factors in alcohol- and hepatitis B virus-related liver fibrosis"],"prefix":"10.1097","author":[{"given":"Yutong","family":"Dong","sequence":"first","affiliation":[{"name":"Gastroenteric Medicine and Digestive Endoscopy Center, The Second Hospital of Jilin University, Changchun, Jilin 130021, China"},{"name":"Department of Hepatology, The First Hospital of Jilin University, Changchun, Jilin 130021, China"},{"name":"Key Laboratory of Zoonosis Research, Ministry of Education, Jilin University, Changchun, Jilin 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtian","family":"Guan","sequence":"additional","affiliation":[{"name":"Bioinformatics Laboratory, The First Hospital of Jilin University, Changchun, Jilin 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baisong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Hepatology, The First Hospital of Jilin University, Changchun, Jilin 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyue","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China"},{"name":"China-Singapore Belt and Road Joint Laboratory on Liver Disease Research, Changchun, Jilin 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatology, The First Hospital of Jilin University, Changchun, Jilin 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Niu","sequence":"additional","affiliation":[{"name":"Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, Jilin 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"R1-20260616","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"R2-20260616","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"R3-20260616","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12072-017-9808-z","article-title":"New concepts on the clinical course and stratification of compensated and decompensated cirrhosis","volume":"12","author":"D\u2019Amico","year":"2018","journal-title":"Hepatol Int"},{"key":"R4-20260616","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cnc.2022.04.004","article-title":"Hepatocellular Carcinoma","volume":"34","author":"Gilles","year":"2022","journal-title":"Crit Care Nurs Clin North Am"},{"key":"R5-20260616","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J Clin Invest"},{"key":"R6-20260616","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: Mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"R7-20260616","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.3748\/wjg.v20.i23.7260","article-title":"Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update","volume":"20","author":"Elpek","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R8-20260616","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R9-20260616","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.3390\/ijms22136836","article-title":"Annexin A2 in fibrinolysis, inflammation and fibrosis","volume":"22","author":"Lim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R10-20260616","first-page":"131","article-title":"ANXA2, PRKCE, and OXT are critical differentially genes in nonalcoholic fatty liver disease","volume":"12","author":"Rezaei Tavirani","year":"2019","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"R11-20260616","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/mc.22818","article-title":"Identification of chromatin-accessible domains in non-alcoholic steatohepatitis-derived hepatocellular carcinoma","volume":"57","author":"Dechassa","year":"2018","journal-title":"Mol Carcinog"},{"key":"R12-20260616","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nut.2018.12.001","article-title":"Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease","volume":"62","author":"Arendt","year":"2019","journal-title":"Nutrition"},{"key":"R13-20260616","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166413","article-title":"The Annexin A2-notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression","volume":"1868","author":"Wang","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"R14-20260616","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00535-017-1404-4","article-title":"Human hepatic stellate cell isolation and characterization","volume":"53","author":"Shang","year":"2018","journal-title":"J Gastroenterol"},{"key":"R15-20260616","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wi\u015bniewski","year":"2009","journal-title":"Nat Methods"},{"key":"R16-20260616","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.virs.2022.07.013","article-title":"IFN-\u03b21b induces OAS3 to inhibit EV71 via IFN-\u03b21b\/JAK\/STAT1 pathway","volume":"37","author":"Zheng","year":"2022","journal-title":"Virol Sin"},{"key":"R17-20260616","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s12250-021-00346-2","article-title":"ATP1B3 restricts hepatitis B virus replication via reducing the expression of the envelope proteins","volume":"36","author":"Zhang","year":"2021","journal-title":"Virol Sin"},{"key":"R18-20260616","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/jgh.16221","article-title":"Multi-omics profiling of primary hepatic stellate cells from advanced liver fibrosis patients reveals distinctive molecular signatures","volume":"38","author":"Dong","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"R19-20260616","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1359-6101(02)00027-8","article-title":"IL-6 in autoimmune disease and chronic inflammatory proliferative disease","volume":"13","author":"Ishihara","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"R20-20260616","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of Jak-STAT signaling in the immune system","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat Immunol"},{"key":"R21-20260616","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O\u2019Shea","year":"2015","journal-title":"Annu Rev Med"},{"key":"R22-20260616","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0037-1601350","article-title":"Inflammasomes in liver fibrosis","volume":"37","author":"Alegre","year":"2017","journal-title":"Semin Liver Dis"},{"key":"R23-20260616","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"R24-20260616","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/495156","article-title":"The effect of inflammatory cytokines in alcoholic liver disease","volume":"2013","author":"Kawaratani","year":"2013","journal-title":"Mediators Inflamm"},{"key":"R25-20260616","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2022.03.055","article-title":"Transcriptomic analysis reveals a novel regulatory factor of ECHDC1 involved in lipid metabolism of non-alcoholic fatty liver disease","volume":"605","author":"Ma","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"R26-20260616","article-title":"Identification of immune microenvironment changes and the expression of immune-related genes in liver cirrhosis","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"R27-20260616","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s12967-022-03692-1","article-title":"The p-STAT3\/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis","volume":"20","author":"Feng","year":"2022","journal-title":"J Transl Med"},{"key":"R28-20260616","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/jb\/mvab088","article-title":"ETV4 mediates the Wnt\/\u03b2-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression","volume":"170","author":"Sun","year":"2021","journal-title":"J Biochem"},{"key":"R29-20260616","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/carcin\/bgaa055","article-title":"A novel regulatory loop miR-101\/ANXA2\/EGR1 mediates malignant characteristics of liver cancer stem cells","volume":"42","author":"Ma","year":"2021","journal-title":"Carcinogenesis"},{"key":"R30-20260616","doi-asserted-by":"crossref","first-page":"152386","DOI":"10.1016\/j.prp.2019.03.015","article-title":"High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis","volume":"215","author":"Tang","year":"2019","journal-title":"Pathol Res Pract"},{"key":"R31-20260616","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3748\/wjg.v26.i18.2126","article-title":"Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment","volume":"26","author":"Qiu","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R32-20260616","doi-asserted-by":"crossref","first-page":"G881","DOI":"10.1152\/ajpgi.00006.2004","article-title":"Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease","volume":"286","author":"Rao","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"Suppl 3","key":"R33-20260616","first-page":"S30","article-title":"Regulation of Kupffer cell activity during chronic ethanol exposure: role of adiponectin","volume":"21","author":"Park","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"R34-20260616","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","article-title":"Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells","volume":"37","author":"Paik","year":"2003","journal-title":"Hepatology"},{"key":"R35-20260616","doi-asserted-by":"crossref","first-page":"G497","DOI":"10.1152\/ajpgi.00171.2004","article-title":"Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease","volume":"287","author":"McClain","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"R36-20260616","first-page":"180s","article-title":"Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease","volume":"29","author":"McClain","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"R37-20260616","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","article-title":"Cytokines in alcoholic and nonalcoholic steatohepatitis","volume":"343","author":"Tilg","year":"2000","journal-title":"N Engl J Med"},{"key":"R38-20260616","first-page":"92","article-title":"Cytokines, STATs and liver disease","volume":"2","author":"Gao","year":"2005","journal-title":"Cell Mol Immunol"},{"key":"R39-20260616","doi-asserted-by":"crossref","first-page":"271","DOI":"10.14218\/JCTH.2015.00024","article-title":"IL-6 plays a crucial role in HBV infection","volume":"3","author":"Lan","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"R40-20260616","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3390\/cancers11111704","article-title":"Jak-Stat signaling induced by interleukin-6 family cytokines in hepatocellular carcinoma","volume":"11","author":"Lokau","year":"2019","journal-title":"Cancers (Basel)"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000004155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:00:59Z","timestamp":1781596859000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000004155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000004155","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"2025-12-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}